Production (Stage)
AEON Biopharma, Inc.
AEON
$0.534
-$0.015-2.73%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.10M | 2.08M | -6.17M | 164.11M | -118.02M |
| Total Depreciation and Amortization | 19.00K | 23.00K | 25.00K | 24.00K | 25.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.21M | -6.02M | 3.77M | -170.14M | 109.30M |
| Change in Net Operating Assets | -5.81M | 3.30M | -577.00K | -2.11M | 96.00K |
| Cash from Operations | -7.91M | -621.00K | -2.96M | -8.12M | -8.60M |
| Capital Expenditure | -4.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 0.00 | 10.00M | 5.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.35M | 97.00K | 50.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.35M | 97.00K | 50.00K | 10.00M | 5.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.43M | -524.00K | -2.91M | 1.88M | -3.60M |